DK0661987T3 - Morphogeninduceret leverregeneration - Google Patents
Morphogeninduceret leverregenerationInfo
- Publication number
- DK0661987T3 DK0661987T3 DK93922700T DK93922700T DK0661987T3 DK 0661987 T3 DK0661987 T3 DK 0661987T3 DK 93922700 T DK93922700 T DK 93922700T DK 93922700 T DK93922700 T DK 93922700T DK 0661987 T3 DK0661987 T3 DK 0661987T3
- Authority
- DK
- Denmark
- Prior art keywords
- liver function
- compositions
- methods
- mammal
- correcting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94623892A | 1992-09-16 | 1992-09-16 | |
US2933593A | 1993-03-04 | 1993-03-04 | |
US4051093A | 1993-03-31 | 1993-03-31 | |
PCT/US1993/008808 WO1994006449A2 (en) | 1992-09-16 | 1993-09-16 | Morphogen-induced liver regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0661987T3 true DK0661987T3 (da) | 1998-09-14 |
Family
ID=27363459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93922700T DK0661987T3 (da) | 1992-09-16 | 1993-09-16 | Morphogeninduceret leverregeneration |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0661987B1 (da) |
JP (1) | JP3973050B2 (da) |
AT (1) | ATE162078T1 (da) |
AU (1) | AU681356B2 (da) |
CA (1) | CA2144514C (da) |
DE (1) | DE69316379T2 (da) |
DK (1) | DK0661987T3 (da) |
ES (1) | ES2114073T3 (da) |
GR (1) | GR3026602T3 (da) |
WO (1) | WO1994006449A2 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2363965C (en) | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
US6287816B1 (en) * | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
US5738848A (en) * | 1994-02-16 | 1998-04-14 | Kamada; Naoshi | Immunosuppressive compounds and method of preparing same |
AU7142000A (en) * | 1996-05-06 | 2001-01-25 | Curis, Inc. | Morphogen treatment for chronic renal failure |
US6498142B1 (en) * | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
AU757969B2 (en) * | 1996-05-06 | 2003-03-13 | Stryker Corporation | Therapies for chronic renal failure |
ATE278414T1 (de) | 1997-05-05 | 2004-10-15 | Curis Inc | Therapien zur behandlung von akutem nierenversagen |
AU7473098A (en) * | 1997-05-07 | 1998-11-27 | Biogen, Inc. | Novel therapies for cystic kidney disease |
EP2309261A1 (en) | 1997-05-30 | 2011-04-13 | Stryker Corporation | Methods for evaluating tissue morphogenesis and morphogenic activity |
JP2002507896A (ja) * | 1997-07-10 | 2002-03-12 | ジェネティックス・インスチチュート・インコーポレーテッド | Wa545組成物 |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
EP2801616A1 (en) | 2002-06-17 | 2014-11-12 | Thrasos Innovation, Inc. | Single domain TDF-related compounds and analogs thereof |
CA2561809A1 (en) * | 2004-03-31 | 2005-10-20 | Xencor, Inc. | Bmp-7 variants with improved properties |
CA2571218C (en) | 2004-06-17 | 2015-11-03 | William D. Carlson | Tdf-related compounds and analogs thereof |
JP2008169116A (ja) * | 2005-04-18 | 2008-07-24 | Tokyo Medical & Dental Univ | Bmp−7を含む抗c型肝炎ウイルス剤 |
DK2497780T3 (da) | 2005-09-20 | 2015-06-01 | Thrasos Innovation Inc | TDF-relaterede forbindelser og analoger deraf |
US20110002897A1 (en) | 2009-06-11 | 2011-01-06 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4396601A (en) | 1980-03-26 | 1983-08-02 | The Regents Of The University Of Calif. | Gene transfer in intact mammals |
US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
EP0228458B2 (en) | 1985-07-05 | 1997-10-22 | Whitehead Institute For Biomedical Research | Epithelial cells expressing foreign genetic material |
CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
EP0408649A4 (en) | 1988-04-08 | 1991-11-27 | Genetics Institute, Inc. | Bone and cartilage inductive compositions |
US5011691A (en) | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
US4968590A (en) | 1988-04-08 | 1990-11-06 | Stryker Corporation | Osteogenic proteins and polypeptides |
HU201095B (en) | 1988-06-14 | 1990-09-28 | Richter Gedeon Vegyeszet | New peptides inhibiting the activity of the immune system and pharmaceutical compositions comprising same, as well as process for producing these peptides and compositions |
US5104858A (en) | 1988-09-29 | 1992-04-14 | Yale University | Sensitizing multidrug resistant cells to antitumor agents |
US5068323A (en) | 1989-04-21 | 1991-11-26 | Merck & Co., Inc. | Thermally re-arranged FK-506 derivatives having immunosuppressant activity |
CA2031532C (en) | 1989-04-25 | 2003-02-25 | Joseph P. Vacanti | Method for implanting large volumes of cells on polymeric matrices |
US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
EP1142581A3 (en) | 1990-11-27 | 2002-09-11 | American National Red Cross | Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
ATE203166T1 (de) | 1991-03-11 | 2001-08-15 | Curis Inc | Protein-induzierende morphogenese |
EP0601106B2 (en) * | 1991-08-30 | 2003-11-05 | Curis, Inc. | Morphogen-induced modulation of inflammatory response |
US9103603B2 (en) | 2009-10-28 | 2015-08-11 | Tai-Her Yang | Thermal conductive cylinder installed with U-type core piping and loop piping |
-
1993
- 1993-09-16 ES ES93922700T patent/ES2114073T3/es not_active Expired - Lifetime
- 1993-09-16 DE DE69316379T patent/DE69316379T2/de not_active Expired - Fee Related
- 1993-09-16 AT AT93922700T patent/ATE162078T1/de not_active IP Right Cessation
- 1993-09-16 WO PCT/US1993/008808 patent/WO1994006449A2/en active IP Right Grant
- 1993-09-16 CA CA002144514A patent/CA2144514C/en not_active Expired - Lifetime
- 1993-09-16 AU AU51623/93A patent/AU681356B2/en not_active Expired
- 1993-09-16 DK DK93922700T patent/DK0661987T3/da active
- 1993-09-16 JP JP50834294A patent/JP3973050B2/ja not_active Expired - Lifetime
- 1993-09-16 EP EP93922700A patent/EP0661987B1/en not_active Expired - Lifetime
-
1998
- 1998-04-10 GR GR980400798T patent/GR3026602T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP3973050B2 (ja) | 2007-09-05 |
ES2114073T3 (es) | 1998-05-16 |
AU681356B2 (en) | 1997-08-28 |
AU5162393A (en) | 1994-04-12 |
EP0661987B1 (en) | 1998-01-14 |
EP0661987A1 (en) | 1995-07-12 |
WO1994006449A2 (en) | 1994-03-31 |
ATE162078T1 (de) | 1998-01-15 |
CA2144514A1 (en) | 1994-03-31 |
DE69316379T2 (de) | 1998-07-30 |
DE69316379D1 (de) | 1998-02-19 |
CA2144514C (en) | 2002-03-26 |
WO1994006449A3 (en) | 1994-09-01 |
JPH08501558A (ja) | 1996-02-20 |
GR3026602T3 (en) | 1998-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0661987T3 (da) | Morphogeninduceret leverregeneration | |
BR9507506A (pt) | Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico | |
DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
NO963742L (no) | Fremgangsmåte til å stimulere hematopoese med hemaglobin | |
ATE276764T1 (de) | Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen | |
PT1062321E (pt) | Utilizacoes para celulas estaminais mesenquimais humanas nao autologas | |
DK1206261T3 (da) | Farmaceutiske præparater, der omfatter clavuansyre eller derivater deraf, til behandlingen af adfærdsmæssige sygdomme | |
SE8903914D0 (sv) | Oral composition for the treatment of inflammatory bowel diseases | |
DE69710065T2 (de) | Androsten-derivate | |
DK1246826T3 (da) | Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
DK0817646T3 (da) | Fremgangsmåder til behandling af inflammation og præparater derfor | |
ATE253117T1 (de) | Adenovirus e4 proteine für induktion von zelltod | |
NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
EA200000909A1 (ru) | ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА | |
DE60024969D1 (de) | 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten | |
DE69821227D1 (de) | Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen | |
NO960866D0 (no) | Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler | |
DE69803052D1 (de) | Therapeutischer viraler wirkstoff, welcher das fortschreiten von tumoren stoppt | |
RU98111356A (ru) | Способ лечения ожогового шока | |
RU96102282A (ru) | Способ терапии поллиноза |